Trial of Mesalamine for the Treatment of Active Microscopic Colitis

Completed · Phase 2/Phase 3

Conditions studied: Microscopic Colitis, Diarrhea

In brief

Subjects must be 18 years old and older, have diarrhea and microscopic colitis. Pregnant or nursing females are excluded. They can't have other untreated diarrheal conditions. Subjects will receive medication for 8 weeks, followed by sigmoidoscopy with biopsies. The subjects will be monitored weekly. A pathologist will review pre and post treatment biopsies. Subjects that show improvement will be followed for 4 weeks post medication.

Key facts

Study ID

NCT00952952

Run by

Mayo Clinic

People needed

70

Starts

2007-02-01

Expected to finish

2007-11-01

Last updated by the study team

2011-05-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must be 18 years old and older.
• Have diarrhea and microscopic colitis.
• They need to have a colon biopsy done at the Mayo Clinic in Rochester, MN within a year of enrollment.

You may not qualify if…

• None.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.